Alkem Lab (ALKEM)
STALWARTFairStock Score: 60/100 — STEADY
Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 1/2 · Dividend: 0/1
Key Financials
| Current Price | ₹5,516.6 |
| Market Cap | ₹67,428.68 Cr |
| P/E Ratio | 28.09 |
| ROCE | 20.38% |
| ROE | 19.78% |
| Dividend Yield | 0.8% |
| Profit Growth | 10.13% |
| Debt/Equity | 0.18 |
| Sales Growth | 11.73% |
| Free Cash Flow | ₹62,500 Cr |
| Promoter Holding | 51.2% |
| 52-Week Range | ₹4,716.2 — ₹5,933.5 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹1,002.37 |
Alkem Lab trades with a P/E ratio of 28.09, ROCE of 20.38%, ROE of 19.78%, profit growth of 10.13%, debt-to-equity of 0.18. The FairStock Score of 60/100 suggests mixed fundamentals — some metrics look solid while others need improvement.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer